RNU6-765P

Across TCGA pan-cancer cohorts, RNU6-765P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-765P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RNU6-765P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU6-765P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ESCA, LAML, and LGG are the cancer types where RNU6-765P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	III,IV	1.000	0.286	.018	18	view →
LAML	DFS	Tertile	All	0.081	0.572	.005	18	view →
LGG	DFS	Tertile	All	0.269	0.757	.003	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6-765P–ESCA (DFS)

Open the ESCA breakdown →